{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:25:39Z","timestamp":1774941939116,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Modulation of vagal tone using electrical vagal nerve stimulation or pharmacological acetylcholinesterase inhibition by donepezil exerts beneficial effects in an animal model of chronic heart failure (CHF). Considering different treatment mechanisms underlying renin\u2013angiotensin system (RAS) suppression and parasympathetic activation, we hypothesized that parasympathetic activation together with RAS inhibition could attenuate CHF progression. To test this hypothesis, we investigated the therapeutic effects of a combination of donepezil and losartan in CHF rats with extensive myocardial infarction (MI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Rats (n\u2009=\u200985) that had survived extensive MI were implanted with a blood pressure transmitter and were randomly assigned to receive either a combination of donepezil and losartan (DLT group) or losartan alone (LT group). Compared with the LT group, the DLT group showed a significantly lower heart rate without hypotension. DLT therapy further improved 280-day overall survival relative to the LT group (31% vs. 8%, P\u2009=\u20090.022) by preventing cardiac dysfunction (LV dP\/dtmax, 4064\u2009\u00b1\u2009170 vs. 3430\u2009\u00b1\u2009117\u2009mmHg\/s, P\u2009&amp;lt;\u20090.01; LV end-diastolic pressure, 17\u2009\u00b1\u20092 vs. 22\u2009\u00b1\u20092\u2009mmHg, P\u2009&amp;lt;\u20090.05). DLT therapy was also associated with lower plasma BNP and catecholamine levels, lower cardiac angiotensin II concentrations, and higher capillary density in the peri-infarct region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined treatment with donepezil and losartan prevented the progression of cardiac dysfunction and improved the long-term survival of CHF rats with extensive MI, suggesting that this combination could be a novel pharmacotherapy for severe CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.164","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T11:25:22Z","timestamp":1410175522000},"page":"1056-1065","source":"Crossref","is-referenced-by-count":29,"title":["Adding the Acetylcholinesterase Inhibitor, Donepezil, to Losartan Treatment Markedly Improves Long-Term Survival in Rats with Chronic Heart Failure"],"prefix":"10.1093","volume":"16","author":[{"given":"Meihua","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Sugimachi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"key":"2026011921124597700_ejhf164-bib-0001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2026011921124597700_ejhf164-bib-0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0735-1097(91)90602-6","article-title":"Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure","volume":"18","author":"Binkley","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2026011921124597700_ejhf164-bib-0003","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure: a combinatorial approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0004","doi-asserted-by":"crossref","first-page":"IV14","DOI":"10.1161\/circ.102.suppl_4.IV-14","article-title":"Congestive heart failure: fifty years of progress","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0005","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jacc.2003.12.040","article-title":"Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial","volume":"43","author":"Gattis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026011921124597700_ejhf164-bib-0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026011921124597700_ejhf164-bib-0007","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archinte.159.3.225","article-title":"Sympathetic activation in heart failure and its treatment with beta-blockade","volume":"159","author":"Pepper","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026011921124597700_ejhf164-bib-0008","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0009","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"2026011921124597700_ejhf164-bib-0010","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"2026011921124597700_ejhf164-bib-0011","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.170073","article-title":"ACC\/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America","volume":"112","author":"Radford","year":"2005","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0012","first-page":"1","article-title":"Hospitalization for congestive heart failure: United States","volume":"2012","author":"Hall","year":"2000\u20132010","journal-title":"NCHS Data Brief"},{"key":"2026011921124597700_ejhf164-bib-0013","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1161\/01.CIR.96.10.3450","article-title":"Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications","volume":"96","author":"Mortara","year":"1997","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0014","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","article-title":"Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction","volume":"351","author":"La Rovere","year":"1998","journal-title":"Lancet"},{"key":"2026011921124597700_ejhf164-bib-0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","article-title":"Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0016","first-page":"3962","article-title":"Chronic vagal stimulation decreased vasopressin secretion and sodium ingestion in heart failure rats after myocardial infarction","volume":"4","author":"Li","year":"2005","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"2026011921124597700_ejhf164-bib-0017","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","article-title":"Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure","volume":"32","author":"De Ferrari","year":"2011","journal-title":"Eur Heart J"},{"key":"2026011921124597700_ejhf164-bib-0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12471-012-0368-5","article-title":"Vagal stimulation for heart diseases: from animals to men. An example of translational cardiology","volume":"21","author":"Schwartz","year":"2013","journal-title":"Neth Heart J"},{"key":"2026011921124597700_ejhf164-bib-0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(98)00717-1","article-title":"Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat","volume":"361","author":"Lazartigues","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"2026011921124597700_ejhf164-bib-0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/heart.89.8.854","article-title":"Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure","volume":"89","author":"Androne","year":"2003","journal-title":"Heart"},{"key":"2026011921124597700_ejhf164-bib-0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12576-009-0071-5","article-title":"Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure","volume":"60","author":"Okazaki","year":"2010","journal-title":"J Physiol Sci"},{"key":"2026011921124597700_ejhf164-bib-0022","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1253\/circj.CJ-13-0476","article-title":"Donepezil markedly improves long-term survival in rats with chronic heart failure after extensive myocardial infarction","volume":"77","author":"Li","year":"2013","journal-title":"Circ J"},{"key":"2026011921124597700_ejhf164-bib-0023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/CS20060027","article-title":"Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure","volume":"111","author":"Lefebvre","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"2026011921124597700_ejhf164-bib-0024","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12576-010-0096-9","article-title":"Open-loop dynamic and static characteristics of the carotid sinus baroreflex in rats with chronic heart failure after myocardial infarction","volume":"60","author":"Kawada","year":"2010","journal-title":"J Physiol Sci"},{"key":"2026011921124597700_ejhf164-bib-0025","first-page":"247","volume":"70","author":"Suga","year":"1990","journal-title":"Ventricular energetics. Physiol Rev"},{"key":"2026011921124597700_ejhf164-bib-0026","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.111.245092","article-title":"Treatment of chronic heart failure with \u03b2-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology","volume":"109","author":"Bristow","year":"2011","journal-title":"Circ Res"},{"key":"2026011921124597700_ejhf164-bib-0027","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"2026011921124597700_ejhf164-bib-0028","first-page":"H534","article-title":"Vagal stimulation decreases left ventricular contractility mainly through negative chronotropic effect","volume":"273","author":"Matsuura","year":"1997","journal-title":"Am J Physiol"},{"key":"2026011921124597700_ejhf164-bib-0029","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/hc4401.099448","article-title":"Heart rate-independent vagal effect on end-systolic elastance of the canine left ventricle under various levels of sympathetic tone","volume":"104","author":"Nakayama","year":"2001","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0030","doi-asserted-by":"crossref","first-page":"H251","DOI":"10.1152\/ajpheart.01136.2003","article-title":"Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice","volume":"287","author":"Joaquim","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011921124597700_ejhf164-bib-0031","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.wnp.0000229946.01494.4c","article-title":"Acetylcholinesterase inhibition in patients with orthostatic intolerance","volume":"23","author":"Singer","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"2026011921124597700_ejhf164-bib-0032","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","article-title":"Cholinergic control of inflammation","volume":"265","author":"Rosas-Ballina","year":"2009","journal-title":"J Intern Med"},{"key":"2026011921124597700_ejhf164-bib-0033","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"2026011921124597700_ejhf164-bib-0034","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000139382.42506.89","article-title":"Vagal nerve stimulation in chronic heart failure: an antiinflammatory intervention?","volume":"110","author":"Springer","year":"2004","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: possible role during stress and remodeling","volume":"64","author":"Schellings","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2026011921124597700_ejhf164-bib-0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.01.011","article-title":"Healing after myocardial infarction","volume":"66","author":"Ertl","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2026011921124597700_ejhf164-bib-0037","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI0214676","article-title":"A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors","volume":"110","author":"Heeschen","year":"2002","journal-title":"J Clin Invest"},{"key":"2026011921124597700_ejhf164-bib-0038","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.RES.85.2.192","article-title":"Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor","volume":"85","author":"Zheng","year":"1999","journal-title":"Circ Res"},{"key":"2026011921124597700_ejhf164-bib-0039","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0735-1097(95)00506-4","article-title":"Survival after myocardial infarction in rats: captopril versus losartan","volume":"27","author":"Milavetz","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026011921124597700_ejhf164-bib-0040","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"2026011921124597700_ejhf164-bib-0041","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0008-6363(98)00227-2","article-title":"Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats","volume":"41","author":"Richer","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2026011921124597700_ejhf164-bib-0042","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cardiores.2004.09.022","article-title":"Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart","volume":"65","author":"Takahashi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2026011921124597700_ejhf164-bib-0043","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"J Biol Chem"},{"key":"2026011921124597700_ejhf164-bib-0044","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1021\/bi9830516","article-title":"Role of N-glycosylation in the expression and functional properties of human AT1 receptor","volume":"38","author":"Lanct\u00f4t","year":"1999","journal-title":"Biochemistry"},{"key":"2026011921124597700_ejhf164-bib-0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.CIR.72.2.406","article-title":"Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril","volume":"72","author":"Pfeffer","year":"1985","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0046","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.109.157107","article-title":"Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor","volume":"331","author":"Ahmet","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2026011921124597700_ejhf164-bib-0047","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1161\/CIRCULATIONAHA.105.551143","article-title":"Mortality and morbidity remain high despite captopril and\/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"2026011921124597700_ejhf164-bib-0048","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","article-title":"The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease","volume":"34","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.164","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/16\/10\/1056\/66433574\/eurjhf_16_10_1056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/16\/10\/1056\/66433574\/eurjhf_16_10_1056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:14:40Z","timestamp":1768875280000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/16\/10\/1056\/8427662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,9,8]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.164","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,9,8]]}}}